Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 January 2018

Registration Checklist

Remember to bring the following with you
to campus when you register:

  1. Black pen
  2. Your active student
  3. One of the following: Deposit receipt indicating
    prepayment (deposit) of registration fee,
    or
    Proof of a reserved bursary/loan,
    or
    Proof of a granted bursary or loan
  4. If applicable, you will also need:
    Proof of application to the Matriculation Board
    (if you don't have admission to a Bachelor's
    and either a Higher Certificate or any other
    Diploma from another institution)
    Proof of prepayment for residence (if you
    have applied for accommodation on campus
    and your application has been approved)
  5. Identity Document: South African citizens
    should have their ID or a copy thereof
  6. Matriculants will need a copy of the statement
    of their matric results
    (National Senior Certificate or NSC)
    Transferring students will need their
    academic record

Important Information

Do you want to register at the University of the Free State, or do you want to change the modules that you have registered for? All the information you need is on our website, and we will be posting regular updates to our Facebook page with relevant information.

View the Registration snapshot here for a step-by-step guide to the registration process, or follow the guidelines here.

Before you start, keep the following in mind:

Important dates

University reopens: 2 January 2018
Self-service registration opens: 8 January 2018
Academic advice: 29 January - 2 February 2018 and 12-16 February 2018
Lectures start for first semester: 19 February 2018
Self-service registration closes: 23 February 2018

More dates available in the official calendar.

Official UFS email account

To access your UFS email account, go to http://www.ufs4life.ac.za. Please note that the password you use to access your email account is the UFS password that the university has issued to you.

If your password has expired or if you forgot your password, go to https://selfservice.ufs.ac.za to change it. You will receive a one-time pin code via SMS that will grant you access to change your password.

For assistance, you can call the Student Helpdesk at the Department of Information and Communication Technology Services (ICT) on +27 51 401 2442.


 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept